These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 15621143)
1. Prevention of hepatitis B virus recurrence after living donor liver transplantation. Ali H; Egawa H; Uryuhara K; Ogawa K; Kasahara M; Ueda M; Marusawa H; Nabeshima M; Tanaka K Transplant Proc; 2004 Nov; 36(9):2764-7. PubMed ID: 15621143 [TBL] [Abstract][Full Text] [Related]
2. Outcomes of hepatitis B virus recurrence after liver transplantation. Han YS; Lee SK; Joh JW; Kim SJ; Kwon CH; Park JW; Kim DJ; Park JB Transplant Proc; 2006 Sep; 38(7):2123-4. PubMed ID: 16980019 [TBL] [Abstract][Full Text] [Related]
3. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients]. Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179 [TBL] [Abstract][Full Text] [Related]
4. Role of long-term lamivudine treatment of hepatitis B virus recurrence after liver transplantation. Woo HY; Choi JY; Jang JW; You CR; Bae SH; Yoon SK; Yang JM; Choi SW; Han NI; Kim DG J Med Virol; 2008 Nov; 80(11):1891-9. PubMed ID: 18814257 [TBL] [Abstract][Full Text] [Related]
5. Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients. Hsiao LT; Chiou TJ; Liu JH; Chu CJ; Lin YC; Chao TC; Wang WS; Yen CC; Yang MH; Tzeng CH; Chen PM Biol Blood Marrow Transplant; 2006 Jan; 12(1):84-94. PubMed ID: 16399572 [TBL] [Abstract][Full Text] [Related]
6. No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants. Caccamo L; Romeo R; Rossi G; Maggioni M; Radice F; Lunghi G; Colombo M; Fassati LR Transpl Int; 2005 Feb; 18(2):186-92. PubMed ID: 15691271 [TBL] [Abstract][Full Text] [Related]
7. Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation. Ferretti G; Merli M; Ginanni Corradini S; Callejon V; Tanzilli P; Masini A; Ferretti S; Iappelli M; Rossi M; Rivanera D; Lilli D; Mancini C; Attili A; Berloco P Transplant Proc; 2004 Apr; 36(3):535-8. PubMed ID: 15110584 [TBL] [Abstract][Full Text] [Related]
8. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation]. Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352 [TBL] [Abstract][Full Text] [Related]
9. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation]. Lu MQ; Cai CJ; Zhao H; Yang Y; Chen GH Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):742-4. PubMed ID: 16836920 [TBL] [Abstract][Full Text] [Related]
10. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B. Lo CM; Liu CL; Chan SC; Lau GK; Fan ST J Hepatol; 2005 Aug; 43(2):283-7. PubMed ID: 15964658 [TBL] [Abstract][Full Text] [Related]
11. Advances in prophylaxis and treatment of recurrent hepatitis B after liver transplantation. Wang ZF; Zhu ZJ; Shen ZY Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):509-14. PubMed ID: 16286253 [TBL] [Abstract][Full Text] [Related]
12. Lamivudine prophylaxis for hepatitis B virus infection after lung transplantation. Shitrit AB; Kramer MR; Bakal I; Morali G; Ben Ari Z; Shitrit D Ann Thorac Surg; 2006 May; 81(5):1851-2. PubMed ID: 16631684 [TBL] [Abstract][Full Text] [Related]
13. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series. Huang YW; Liu CJ; Lai MY; Lee PH; Tsai MK; Wang SS; Lai MK; Kao JH Clin Ther; 2006 Sep; 28(9):1327-34. PubMed ID: 17062306 [TBL] [Abstract][Full Text] [Related]
14. Living donor liver transplantation for hepatitis B associated liver diseases: a 10-year experience in a single center. Ikegami T; Soejima Y; Ohta R; Taketomi A; Yoshizumi T; Harada N; Kayashima H; Maehara Y Hepatogastroenterology; 2008; 55(85):1445-9. PubMed ID: 18795708 [TBL] [Abstract][Full Text] [Related]
15. Lamivudine therapy in kidney allograft recipients who are seropositive for hepatitis B surface antigen. Filik L; Karakayali H; Moray G; Dalgiç A; Emiroğlu R; Ozdemir N; Colak T; Gür G; Yilmaz U; Haberal M Transplant Proc; 2006 Mar; 38(2):496-8. PubMed ID: 16549158 [TBL] [Abstract][Full Text] [Related]
16. Prophylaxis of recurrent hepatitis B in Chinese patients after liver transplantation using lamivudine combined with hepatitis B immune globulin according to the titer of antibody to hepatitis B surface antigen. Jiao ZY; Jiao Z Transplant Proc; 2007 Jun; 39(5):1533-6. PubMed ID: 17580182 [TBL] [Abstract][Full Text] [Related]
17. Short-term high-dose followed by long-term low-dose hepatitis B immunoglobulin and lamivudine therapy prevented recurrent hepatitis B after liver transplantation. Takaki A; Yagi T; Iwasaki Y; Sadamori H; Matsukawa H; Matsuda H; Shinoura S; Umeda Y; Miyake Y; Terada R; Kobashi H; Sakaguchi K; Tanaka N; Shiratori Y Transplantation; 2007 Jan; 83(2):231-3. PubMed ID: 17264822 [TBL] [Abstract][Full Text] [Related]
18. [Prophylaxsis against recurrance of hepatitis B virus after liver transplantation]. Wu JS; Lu SC; Wang ML; Xia RP; Guo QL; Gao DM; Zhang Y; Liu Y; Li N Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):367-9. PubMed ID: 19469177 [TBL] [Abstract][Full Text] [Related]
19. Reactivation of hepatitis and lamivudine therapy in 11 HBsAg-positive renal allograft recipients: a single centre experience. Murakami R; Amada N; Sato T; Orii T; Kikuchi H; Haga I; Ohashi Y; Okazaki H Clin Transplant; 2006; 20(3):351-8. PubMed ID: 16824154 [TBL] [Abstract][Full Text] [Related]
20. Prophylaxis of hepatitis B virus recurrence after liver transplantation. Testino G; Borro P; Sumberaz A J Gastrointestin Liver Dis; 2009 Jun; 18(2):139-41. PubMed ID: 19565040 [No Abstract] [Full Text] [Related] [Next] [New Search]